Ideaya Biosciences
Clinical trials sponsored by Ideaya Biosciences, explained in plain language.
-
New targeted drug shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-stage study tests a new drug called IDE397 in adults with advanced solid tumors that have a specific genetic change (MTAP deletion) and have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors, either alo…
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New pill could help eye cancer patients keep their eye
Disease control OngoingThis study tests a drug called darovasertib (IDE196) in people with a type of eye cancer called uveal melanoma. The goal is to see if the drug can shrink tumors enough to avoid removing the eye or reduce the need for high-dose radiation. About 160 participants will take the pill …
Phase: PHASE2 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New drug combo shows promise for rare eye cancer that spreads
Disease control OngoingThis study tests a new combination of two drugs (IDE196 and crizotinib) against standard treatments for people with a rare eye cancer (uveal melanoma) that has spread to other parts of the body. The trial includes 420 adults whose cancer cells lack a specific marker (HLA-A2 negat…
Phase: PHASE2, PHASE3 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC